Top Markets
Coin of the day
BioMark Diagnostics Inc. BioMark Diagnostics Inc.

BioMark Diagnostics Inc.

BUX
Rangering i aksjer #26699
BioMark Diagnostics Inc. is an oncology specialist, developing advanced... BioMark Diagnostics Inc. is an oncology specialist, developing advanced diagnostic tools for cancer to enable early detection, continuous patient monitoring, and the assessment of initial treatment efficacy. The firm holds a research partnership with the Icahn School of Medicine, collaborating on clinical trials specifically addressing the early identification of lung cancer. Founded in 2014, its corporate headquarters are situated in Richmond, Canada. BioMark Diagnostics Inc. operates as a subsidiary of Biomark Technologies Inc.
Aksjekurs
$0.36696844
Markedsverdi
$38.56M
Endring (1 dag)
-13.79%
Endring (1 år)
45.45%
Land
CA
Handel BioMark Diagnostics Inc. (BUX)

Kategori

Pris BUX pris med markedsverdi på B
BioMark Diagnostics Inc. BioMark Diagnostics Inc.
BUX
$0.36696844
Markedsverdi av BioMark Diagnostics Inc.(BUX)
Markedsverdi: $38.56M
Per August 2026 har BioMark Diagnostics Inc. en markedsverdi på $38.56M. Dette gjør BioMark Diagnostics Inc. til det 26699th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for BioMark Diagnostics Inc. fra 2014 til 2026
BUX sammenlignet med topp 5 mest populære stocks
Pris på BUX Eiendel B Markedsverdi for B Resultater
BioMark Diagnostics Inc. BioMark Diagnostics Inc.
$50,021.83 $38.56M
$5.257T +13,630,998.25%
BioMark Diagnostics Inc. BioMark Diagnostics Inc.
$43,758.70 $38.56M
$4.599T +11,924,276.83%
BioMark Diagnostics Inc. BioMark Diagnostics Inc.
$39,076.39 $38.56M
$4.107T +10,648,334.55%
BioMark Diagnostics Inc. BioMark Diagnostics Inc.
$34,039.53 $38.56M
$3.577T +9,275,774.10%
BioMark Diagnostics Inc. BioMark Diagnostics Inc.
$26,713.05 $38.56M
$2.807T +7,279,286.76%